article thumbnail

Health Canada expands Orkambi label to include access to infants

Pharmaceutical Technology

This label expansion makes Orkambi the only disease-modifying CF medication available to patients of this age in Canada. This label expansion follows a similar label change in the US in September 2022. Health Canada is granting this new label expansion based on recent results from a Phase III study.

article thumbnail

Sartorius – Octet Label free detection system

Express Pharma

Real-Time, Label-Free, Stress Free Protein Analysis. The Sartorius Octet® systems, built using label-free Bio-Layer Interferometry (BLI) optical technology, offer a fast, robust and fluidics-free approach to protein analysis. Download the brochure and learn more about the Octet® R Series Systems.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmaceutical packaging companies and labelling machines

Pharmaceutical Technology

Download our extensive, free list of the leading pharmaceutical packaging companies and labelling machine manufacturers today.

article thumbnail

PBM Industry Update: Trends, Challenges, and What's Ahead (NEW Live Video Webinar)

Drug Channels

Or, download this spreadsheet and email your registrants information to dcisupport@hmpglobal.com. We recommend that every registrant download the Zoom client software/app. Emerging controversies, challenges, and threats to watch in the industry And much more! This link is unique to the registrant and can only be accessed once.

article thumbnail

Overcoming regulatory issues with investigational medicinal product labelling 

Pharmaceutical Technology

Issues with regulatory requirements and documentation can also cause significant delays, while any inaccuracies in translations on labelling can mean that dosage and storage information is not correctly understood or followed. And accurate labelling and translation are critical for this sector.

article thumbnail

FDA updates stimulant labelling requirements to reduce misuse

Pharmaceutical Technology

According to the FDA update, current labels for these drugs do not have up-to-date warnings about the risks of drug misuse and abuse and fail to mention that most individuals who misuse prescription stimulants source drugs from other family members or peers. Please check your email to download the Report.

article thumbnail

6 Digital Tools at the Center of Healthcare Digitalization [INFOGRAPHIC]

Pharma Marketing Network

Download this infographic and learn which 6 digital tools are at the center of digitalization and how the will influence the future of Pharma marketing in 2021 and beyond. Company Email *.